Narrated by: Samuel Roukin. Not as good as Jones' other works. Looking beyond popular explanations such as geography or superior technology, Hanson argues that it is in fact Western culture and values which have consistently produced superior arms and soldiers.
By Lance E. Edens on 12-23-15. If you want to discover the captivating history of ancient Anatolia, then pay attention.... What sparks curiosity about ancient Anatolia, which makes up most of modern-day Turkey, in the minds of history lovers is the diversity of its peoples throughout its territories and time. During Egypt's Second Intermediate Period, a mysterious foreign group of people, known as the Hyksos, conquered Egypt and established the 15th and 16th Dynasties some time shortly after 1700 BCE. The Mongol Invasions. Trial of the scorching sans gluten. The Battle of Marathon in 490 B. is not only understood as the most decisive event in the struggle between the Greeks and the Persians, but can also be seen as perhaps the most significant moment in our collective history. You can also use it to keep track of your completed quests, recipes, mounts, companion pets, and titles! Add to Wish List failed. The horsemen of the steppes are best known for three characteristics. From the beginning of time, humans lived and worked in Africa, leaving evidence of their existence in the sands of the Sahara Desert and the valleys of the great rivers, such as the Nile and the Niger.
Ancient Civilizations: A Captivating Guide to the Ancient Canaanites, Hittites and Ancient Israel and Their Role in Biblical History. Narrated by: James Cameron Stewart. Their armies threatened states as far flung as the Franks in Western Europe and the Tang Empire in China. Trial of the scorching sands genshin. The Ancient Celts, Second Edition. In fact, other than glory, they left little or nothing of their material culture behind them. Horsemen from the Steppe.
This is more about what the Hyksos is not, this what it is. The Roman Empire and the Silk Routes. Not what i thought it would be. Narrated by: Peter Ganim. By Harald on 02-04-19.
Animals and Pets Anime Art Cars and Motor Vehicles Crafts and DIY Culture, Race, and Ethnicity Ethics and Philosophy Fashion Food and Drink History Hobbies Law Learning and Education Military Movies Music Place Podcasts and Streamers Politics Programming Reading, Writing, and Literature Religion and Spirituality Science Tabletop Games Technology Travel. Well Researched but Poorly Written. Forced removal of entire populations, sieges that decimated entire cities, and wanton destruction of property were all tactics used by the various peoples of the ancient Near East against each other, but the Assyrians were the first people to make war a science. How to do trial of the scorching sands. In this audiobook, you will be led on a journey through almost 2, 000 years of Chinese history, showing you all the ups and downs of those ancient times, the sufferings and joys of the Chinese people, along with their greatest achievements and failures. Long neglected in world history, the Ottoman Empire was a hub of intellectual fervor, geopolitical power, and enlightened pluralistic rule.
It serves 2 main purposes: - It maintains a WoW addon called the Wowhead Looter, which collects data as you play the game! Paul Cartledge, one of the world's foremost scholars of ancient Greece, illuminates the brief but iconic life of Alexander (356-323 B. C. ), king of Macedon, conqueror of the Persian Empire, and founder of a new world order. From the forested margins of Poland to the frozen deserts of Mongolia, from the scorching sands of Persia to the numbing wastes of Siberia, the horsemen of the steppes periodically overrode Europe for 900 years, conquered China, and spread their culture to India and the Middle East. His Conquests, His Empire, His Legacy.
Unfollow podcast failed. By Linda on 11-25-14. By Christopher on 08-29-19. Related to this topic. The conquered territory was larger than the Roman Empire at its greatest expansion, and it was claimed for the Arabs in roughly half the time. History of the other part of Europe. Sultan Selim, His Ottoman Empire, and the Making of the Modern World. By D. Buxman on 07-06-20. Never Greater Slaughter. By Than on 10-06-20. By Tom Marshall on 12-20-21. In just over a hundred years - from the death of Muhammad in 632 to the beginning of the Abbasid Caliphate in 750 - the followers of the Prophet swept across the whole of the Middle East, North Africa, and Spain. By Eternl Rayne on 12-27-19. Narrated by: Jonathan Davis, Jack Weatherford.
Check back soon for updates. Why is this author considered an expert scholar of Ancient Greece? The Sea Peoples remain as mysterious as they were influential; while the Egyptians documented their presence and the wars against them, it has never been clear exactly where the Sea Peoples originated or what compelled them to invade various parts of the region with massive numbers. For 2, 500 years, the Celts have continued to fascinate those who have come into contact with them, yet their origins have remained a mystery and even today are the subject of heated debate among historians and archaeologists. The Mongol army led by Genghis Khan subjugated more lands and people in 25 years than the Romans did in 400. The Hunt for a New Past. By Joey on 05-31-20. Lives and Legends of Warrior Women across the Ancient World. Further chapters examine the development of Palmyra as a leading caravan city on the edge of Roman Syria and consider trade ventures through the Tarim territories that led Roman merchants to Han China. Nothing but Glory: The Right Form of War Series, Book 2. Among the extensive writing available about the history of ancient Greece, there is precious little about the city-state of Thebes. It uploads the collected data to Wowhead in order to keep the database up-to-date!
Following the progress of human aggression in its full historical sweep, from the strangely ritualistic combat of Stone Age peoples to the warfare of mass destruction in the present age, his illuminating and lively narrative gives us all the world's great warrior cultures.
Alternative analysis methods for time to event endpoints under nonproportional hazards: a comparative analysis. Weber S, van der Leest P, Donker HC, Schlange T, Timens W, Tamminga M, et al. Role of Modelling and Simulation in Regulatory Decision Making in Europe. Population Approach Group Europe (PAGE). Cpcd0801 - Name Class Date CONCEPTUAL PHYSICS Concept-Development Practice Page 8-1 Momentum 1. A moving car has momentum. If it moves twice as fast | Course Hero. Wilkerson J, Abdallah K, Hugh-Jones C, Curt G, Rothenberg M, Simantov R, et al. PAGE 2022;Abstr 9992 Funding.
CtDNA predicts overall survival in patients with NSCLC treated with PD-L1 blockade or with chemotherapy. Maitland ML, Wilkerson J, Karovic S, Zhao B, Flynn J, Zhou M, et al. Bruno R, Mercier F, Claret L. Evaluation of tumor size response metrics to predict survival in oncology clinical trials. A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis. This perspective paper presents recent developments and future directions to enable wider and robust use of model-based decision frameworks based on pharmacological endpoints. Concept development practice page 8.1.0. Industrial perspective on the benefits realized from the FDA's model-informed drug development paired meeting pilot program. Food and Drug Administration Oncologic Drugs Advisory Committee, April 27-29, 2021.. Accessed October 27, 2022. Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics.
Michaelis LC, Ratain MJ. Benzekri S, Karlsen M, El Kaoutari A, Bruno R, Neubert A, Mercier F, et al. Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance. Claret L, Gupta M, Han K, Joshi A, Sarapa N, He J, et al. Estimation of tumour regression and growth rates during treatment in patients with advanced prostate cancer: a retrospective analysis. Kerioui M, Bertrand J, Bruno R, Mercier F, Guedj J, Desmée S. Modelling the association between biomarkers and clinical outcome: An introduction to nonlinear joint models. Supporting decision making and early prediction of survival for oncology drug development using a pharmacometrics-machine learning based model. Gong Y, Mason J, Shen YL, Chang E, Kazandjian D, Blumenthal GM, et al. Burzykowski T, Coart E, Saad ED, Shi Q, Sommeijer DW, Bokemeyer C, et al. Shah M, Rahman A, Theoret MR, Pazdur R. The drug-dosing conundrum in oncology—when less is more. Concept development practice page 8.1.1. Evaluation of salivary exosomal chimeric GOLM1-NAA35 RNA as a potential biomarker in esophageal carcinoma. Kerioui M, Desmée S, Mercier F, Lin A, Wu B, Jin JY, et al. Evaluation of tumor size response metrics to predict overall survival in Western and Chinese patients with first-line metastatic colorectal cancer. Model-based predictions of expected anti-tumor response and survival in phase III studies based on phase II data of an investigational agent.
CPT Pharmacomet Syst Pharm. Duda M, Chan P, Bruno R, Jin YJ, Lu J. Longitudinal tumor size and neutrophil-to-lymphocyte ratio are prognostic biomarkers for overall survival in patients with advanced non-small cell lung cancer treated with durvalumab. Modeling tumor evolutionary dynamics to predict clinical outcomes for patients with metastatic colorectal cancer: a retrospective analysis.
Rent or buy this article. Bruno R, Marchand M, Yoshida K, Chan P, Li H, Zhu W, et al. Dynamic changes of circulating tumor DNA predict clinical outcome in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors. Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab.
Ribba B, Holford NH, Magni P, Troconiz I, Gueorguieva I, Girard P, et al. An FDA analysis of the association of tumor growth rate and overall and progression-free survival in metastatic non-small cell lung cancer (NSCLC) patients. 2022;Abstr 10276.. Sheiner LB. Zhou J, Liu Y, Zhang Y, Li Q, Cao Y. Multistate pharmacometric model to define the impact of second-line immunotherapies on the survival outcome of IMpower131 study.
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. Stuck on something else? A disease model for multiple myeloma developed using real world data. New guidelines to evaluate the response to treatment in solid tumors. Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR-mutant non-small cell lung cancer. Netterberg I, Karlsson MO, Terstappen LWMM, Koopman M, Punt CJA, Friberg LE. PAGE 2021;Abstr 9878. Visal TH, den Hollander P, Cristofanilli M, Mani SA. Prices may be subject to local taxes which are calculated during checkout. Ethics declarations. Bratman SV, Yang SYC, Lafolla MAJ, Liu Z, Hansen AR, Bedard PL, et al. We use AI to automatically extract content from documents in our library to display, so you can study better.
Assessing the impact of organ-specific lesion dynamics on survival in patients with recurrent urothelial carcinoma treated with atezolizumab or chemotherapy. Beumer JH, Chu E, Salamone SJ. Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology. Laurie M, Lu J. Neural ordinary differential equations for tumor dynamics modeling and overall survival predictions. A multistate model for early decision-making in oncology. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Colomban O, Tod M, Leary A, Ray-Coquard I, Lortholary A, Hardy-Bessard AC, et al. Mathew M, Zade M, Mezghani N, Patel R, Wang Y, Momen-Heravi F. Extracellular vesicles as biomarkers in cancer immunotherapy. Chan P, Marchand M, Yoshida K, Vadhavkar S, Wang N, Lin A, et al. Mezquita L, Preeshagul I, Auclin E, Saravia D, Hendriks L, Rizvi H, et al. Evaluation of continuous tumor-size-based end points as surrogates for overall survival in randomized clinical trials in metastatic colorectal cancer. Food and Drug Administration. Claret L, Girard P, O'Shaughnessy J, Hoff P, Van Cutsem E, Blum J, et al.
Lin RS, Lin J, Roychoudhury S, Anderson KM, Hu T, Huang B, et al. Receive 24 print issues and online access. Mushti SL, Mulkey F, Sridhara R. Evaluation of overall response rate and progression-free survival as potential surrogate endpoints for overall survival in immunotherapy trials. Sène M, Mg Taylor J, Dignam JJ, Jacqmin-Gadda H, Proust-Lima C. Individualized dynamic prediction of prostate cancer recurrence with and without the initiation of a second treatment: development and validation. Yin A, van Hasselt JGC, Guchelaar HJ, Friberg LE, Moes DJAR. Early modeled longitudinal CA-125 kinetics and survival of ovarian cancer patients: a GINECO AGO MRC CTU study. Stat Methods Med Res.
Prediction of overall survival in patients across solid tumors following atezolizumab treatments: a tumor growth inhibition-overall survival modeling framework. Ethics approval and consent to participate. Maitland ML, O'Cearbhaill RE, Gobburu J.